Accelerating dementia pathway technologies

Not Applicable

Completed

• Conditions: Alzheimer's Disease, Dementia, Mild Cognitive Impairment; Nervous System Diseases

• Registration Number: ISRCTN16596456
• Lead Sponsor: Cognetivity Ltd.

Brief Summary

2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/34932495/ (added 22/12/2021) 2023 Other publications in https://doi.org/10.3389/fpubh.2023.1240901 Health economic analysis (added 02/10/2023) 2023 Results article in https://doi.org/10.3389/fnagi.2023.1243316 (added 02/10/2023)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-03-09
• Study Completion: 2021-09-30
• Last Update Posted: 16 October 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 99

Inclusion Criteria

Patients aged between 55-90 years old at the time of AV1 who are referred to the memory clinic who have the capacity to consent

Exclusion Criteria

1. Upper limb arthropathy or motor dysfunction that limits the use of a tablet computer
2. Visual impairment severe enough to limit the use of a tablet computer. As guidance participants who cannot read the small print in a newspaper (even with corrected vision) should be excluded
3. Patients with a known diagnosis of Dementia
4. Patients already receiving Cholinesterase Inhibitors and/or Memantine

Study & Design

• Study Type: Observational
• Study Design: Not specified